Loading...
| Jan 01, 1970 | Daily Report |
| RISING BHARAT | News Count (102633) | |
20351. Over 14 million Covid-19 vaccine doses administered in India: Government
India Fights Corona: Vaccination Drive and Initiatives
English
India
Hindustan Times
|
- India Total doses administered: 1,48,55,073
- People above 60 years: 2,08,791
- Health Care Workers: 93,03,048
- Front Line Workers: 53,43,219
20352. India may grant emergency use authorisation to Russian 'Sputnik V' COVID-19 vaccine
Make in India / Atmanirbhar
->
Make in India- Public Health and Infrastructure
English
India
Business Today
|
- The Lancet had stated that Russia's experimental COVID-19 vaccine Sputnik V is 91.6 per cent affective against coronavirus infection. These results are based on Phase 3 trials of the vaccine in which 20,000 people had participated
- India might grant emergency use authorisation to Russia's Sputnik V COVID-19 vaccine this month or the next.
- "India is a key partner in terms of production of vaccine and we expect that there'll be a restricted emergency use order for the Sputnik V vaccine...this month or next. After that we will be able to start our vaccine delivery to India," Kirill Dmitriev, Russian Direct Investment Fund chief told ANI. Russian Direct Investment Fund (Russia's sovereign fund) is marketing Sputnik V vaccine in foreign countries.
20353. Corona Vaccine: स्वास्थ्य मंत्रालय बोला, कोरोना वैक्सीन लेने वाले 97 फीसदी से ज्यादा लोग संतुष्ट
India Fights Corona: Vaccination Drive and Initiatives
Hindi
India
NBT
|
- केंद्रीय स्वास्थ्य मंत्रालय ने कहा कि जिन 5.12 लाख लोगों को कोविड-19 का टीका दिया गया उनमें से 97 प्रतिशत से अधिक लोगों ने टीकाकरण प्रकिया के प्रति संतोष जताया है।
- उन्होंने कहा कि इस प्रकिया में 37 लाख लोगों में से 5,12,128 लोगों से उनकी प्रतिक्रिया मिली है।
- .
20354. Kerala Chief Minister Urges People To Take Covaxin Without Hesitation
India Fights Corona: Vaccination Drive and Initiatives
English
Kerala
NDTV
|
- People had some doubts about the Covaxin, manufactured by the Bharat Biotech with the support of the ICMR, he said at a press meet.
- There was some reluctance among the public to take the vaccine as part of the delay in getting the results of its third phase trials, he said.
- "ICMR has now released the interim results of the third phase clinical trials. According to it, the vaccine has shown an interim efficacy of 81 per cent in preventing COVID-19," Mr Vijayan said.
- It has also been reported that it can prevent the viral infection with very severe symptoms and effectively -- coronavirus related deaths, he said.
- As per ICMR, Covaxin also has the ability to neutralize the UK variant strain of SARS-CoV-2.
- "Therefore, based on these evidence, people should be ready to accept Covaxin along with Covishield vaccine," the Chief Minister added.
- Kerala now has adequate stock of COVID-19 vaccine and the union health minister has informed that 21 lakh doses would reach the state on March 9, he said.
- "It shows that the disease tends to subside very rapidly in the state. In the last one week alone, the number of patients has dropped by 13 per cent. It dropped by 30 per cent in a month," Mr Vijayan said, quoting figures.
20355. Zimbabwe becomes first African country to authorize the use of India's COVAXIN
India Fights Corona: Vaccination Drive and Initiatives
English
Zimbabwe
Moneycontrol
|
- The Hyderabad-based developers Bharat Biotech on March 3 said that its Covaxin vaccine was 81 percent effective in preventing COVID-19 following a third round of clinicals trials.
- Zimbabwe has authorised the use of India's indigenous vaccine COVAXIN, thereby becoming the first African country to do so.
- The vaccine has been approved for restricted emergency use under clinical trial mode. The vaccine will have to be taken in two doses with 28 days apart.
20356. India Vaccinates Over 1 Million People In One Day For The First Time
Infrastructural Development and Government Schemes
->
Infrastructure
English
India
NDTV
|
- India hit an important milestone on Thursday, vaccinating over a million people in a single day against COVID-19. Some 10.93 lakh people were given the vaccine. India has vaccinated 1.77 crore people so far since launching the drive on January 16.
- The country expanded its vaccination drive from healthcare and frontline workers to seniors above 60 and those over 45 with illnesses and has eased rules for private hospitals to vaccinate people.
- The milestone comes amid a surge in cases in Maharashtra, Kerala, Punjab, Tamil Nadu, Gujarat and Karnataka, accounting for 85.51 per cent of fresh cases, according to the union health ministry.
- A total of 17,407 new infections have been registered in the past 24 hours. Maharashtra reported the highest daily new cases at 9,855. This is the highest number recorded in the state since October 18 when 10,259 new cases were reported.
- It is followed by Kerala with 2,765 while Punjab reported 772 new cases. The total number of cases with UK, South Africa and Brazil variants of SARS-CoV-2 in the country as on date has reached 242, the ministry said.
20357. India To Make J&J's Single-Dose COVID-19 Vaccine Under Quad Initiative to Help Countries In Indo-Pacific Region: Report
India Fights Corona: Vaccination Drive and Initiatives
English
India
SWARAJYA
|
- India will be manufacturing the single-dose COVID-19 vaccine developed by United States (US) based pharmaceutical giant Johnson & Johnson (J&J) as part of the first Quad vaccine initiative
- The entire project will be financed by Japan and the US, while Australia will chip in its logistics capabilities to ship the Made in India vaccines to Southeast Asia and Pacific nations.
- India's role in the entire initiative will project and reinforce the country's credentials as a trustworthy and reliable manufacturer and supplier of quality vaccines.
20358. This Article is From Feb 04, 2021 India's Serum Institute Inks UN Deal For 1.1 Billion Covid Vaccines To 100 Countries
India Fights Corona: Vaccination Drive and Initiatives
English
India
NDTV
|
- The Serum Institute of India (SII) and UNICEF have entered into a long-term supply agreement for the AstraZeneca-Oxford 'Covishield' and the Novavax vaccines, with the UN children's agency saying it will have access to up to 1.1 billion doses of vaccines for around 100 countries.
- While Oxford-AstraZeneca's Covishield is being manufactured by Pune-based Serum Institute, and the Novavax is being produced by US-based Novavax Inc.
- While Oxford-AstraZeneca's Covishield is being manufactured by Pune-based Serum Institute, and the Novavax is being produced by US-based Novavax Inc.
20359. Covid-19: This woman-run Hyderabad firm will supply vaccines to Quad countries
India Fights Corona: Vaccination Drive and Initiatives
English
Telangana
Hindustan Times
|
- Quad leaders in their first leaders' summit on March 12 decided to come up with a joint vaccine initiative.
- Hyderabad's Biological E. Limited has been chosen for this role of producing a billion doses of covid-19 vaccines, while the United States International Development Finance Corporation will provide financial assistance to Biological E.
- Biological E is the world's largest producer of Tetanus vaccine and a leading supplier of snake antivenom in India.
- Biological E is a women-run business which is another reason why USDFC has chosen this company to partner with. This advances its gender equality initiative.
- Biological E is working on four Covid-19 vaccines. It tied up with Johnson and Johnson, pharmaceutical company Dynavax Technologies Corporation, Houston-based Baylor College of Medicine and Ohio University for vaccine developments.
20360. Indian Oil helping with vaccine storage and transportation
India Fights Corona: Vaccination Drive and Initiatives
English
India
Mint
|
- Indian Oil Corporation Ltd (IOC) is helping in the country’ ongoing vaccination drive by helping with cold chain equipment infrastructure in Jammu and Kashmir, Tamil Nadu, Bihar and Manipur.
- India’ largest fuel retailer is procuring cold chain equipment such as ice-line refrigerator (ILR), deep freezer (DF), walk-in-cooler (WIC), walk-in-freezer (WIF) and refrigerated truck (RT) for the storage and transportation of vaccine
- ...